| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1579-2129(06)60272-3 |
| P698 | PubMed publication ID | 16194515 |
| P50 | author | Borja G. Cosio | Q47149799 |
| P2093 | author name string | A Pereira-Vega | |
| E Martínez-Moragón | |||
| J R Villa-Asensi | |||
| A López-Viña | |||
| A de Diego-Damiá | |||
| Area de Asma-SEPAR | |||
| G Rodríguez-Trigo | |||
| J L Aller-Alvarez | |||
| R Agüero-Balbín | |||
| T Bazús-González | |||
| V Plaza-Moral | |||
| P2860 | cites work | Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes | Q24564291 |
| Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice | Q24600284 | ||
| Evidence for different subgroups of difficult asthma in children | Q28363315 | ||
| Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma | Q28363420 | ||
| Non-eosinophilic asthma: importance and possible mechanisms | Q28394141 | ||
| The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma | Q29615637 | ||
| Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study | Q30471472 | ||
| Are asthma medications and management related to deaths from asthma? | Q32032696 | ||
| Pseudo-steroid resistant asthma. | Q33545066 | ||
| Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients | Q33627353 | ||
| Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma | Q33897661 | ||
| Chlamydia pneumoniae and severity of asthma | Q34116681 | ||
| Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome | Q34198787 | ||
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| Glucocorticoid receptor variants: clinical implications. | Q34758698 | ||
| Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications | Q35052918 | ||
| Consensus statement from a conference on treatment of viral respiratory infection-induced asthma in young children | Q35065470 | ||
| The use of cyclosporin in corticosteroid dependent asthma | Q35257675 | ||
| Persistent cough: is it asthma? | Q35261326 | ||
| What do parents of wheezy children understand by "wheeze"? | Q35266349 | ||
| Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack | Q35533546 | ||
| Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol | Q35536031 | ||
| Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma | Q35574100 | ||
| Asthma refractory to glucocorticoids: the role of newer immunosuppressants | Q35627919 | ||
| Phenotype-specific treatment of difficult asthma in children | Q35769226 | ||
| Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma | Q37880264 | ||
| Alternaria as a major allergen for asthma in children raised in a desert environment | Q39042364 | ||
| Glucocorticoid resistance in asthma | Q40376003 | ||
| Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management | Q41537596 | ||
| Parenteral triamcinolone acetonide: an alternative corticosteroid for the treatment of asthma. | Q41732050 | ||
| Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices | Q43590342 | ||
| Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. | Q43601132 | ||
| Persistent wheezing in very young children is associated with lower respiratory inflammation | Q43616367 | ||
| High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma | Q44001275 | ||
| Systematic assessment of difficult-to-treat asthma | Q44600699 | ||
| Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 | ||
| Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients | Q44945639 | ||
| "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids | Q44950357 | ||
| Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study | Q45077392 | ||
| Intramuscular triamcinolone for difficult asthma | Q45235422 | ||
| Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin | Q45732357 | ||
| Unsuspected pseudophysiologic emphysema in chronic persistent asthma | Q46095499 | ||
| ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis | Q47577319 | ||
| Asthma severity and medical resource utilisation | Q47973722 | ||
| Costs of asthma according to the degree of severity. | Q50637174 | ||
| Histopathology of severe childhood asthma: a case series. | Q51664102 | ||
| TGFbeta1 allele association with asthma severity. | Q51729689 | ||
| Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. | Q53310678 | ||
| Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life | Q53636621 | ||
| The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | Q57892223 | ||
| Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol | Q70491239 | ||
| The role of respiratory muscles in the hyperinflation of bronchial asthma | Q71323978 | ||
| Corticosteroid-resistant asthma. Definitions | Q71395418 | ||
| Short term effect of methotrexate in severe steroid-dependent asthma | Q71755595 | ||
| Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma | Q72350899 | ||
| Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society | Q73286389 | ||
| Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity | Q73972310 | ||
| The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms | Q74025531 | ||
| Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity | Q74481818 | ||
| Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group | Q74576219 | ||
| Difficult asthma | Q77720202 | ||
| P433 | issue | 9 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 513-523 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Archivos de Bronconeumologia | Q15758096 |
| P1476 | title | [Guidelines for the diagnosis and management of difficult-to-control asthma] | |
| P478 | volume | 41 |
| Q51592989 | Application of intelligent systems in asthma disease: designing a fuzzy rule-based system for evaluating level of asthma exacerbation. |
| Q50132318 | Computer-aided intelligent system for diagnosing pediatric asthma |
| Q34197997 | Difficult-to-control asthma management through the use of a specific protocol |
| Q64073516 | Is asthma in the elderly different? Functional and clinical characteristics of asthma in individuals aged 65 years and older |
| Q46253794 | Perception of dyspnea and treatment adherence in asthmatic patients |
| Q46535978 | Triamcinolone acetonide in the treatment of corticosteroid-resistant asthma: risks and benefits |
| Q83401039 | [Asthma control. Possible obstacles along the way] |
Search more.